In a report released today, Francois Brisebois from Oppenheimer maintained a Hold rating on Ovid Therapeutics (OVID – Research Report).
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback